SAB Biotherapeutics
SABS
SABS
25 hedge funds and large institutions have $3.38M invested in SAB Biotherapeutics in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$29.9K |
| 2 |
2
Creative Planning
Overland Park,
Kansas
|
$20.8K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$18.7K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$494K |
| 5 |
5
Renaissance Technologies
New York
|
$19.4K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
HWM
26
HB Wealth Management
Atlanta,
Georgia
| – | – | -263,200 | Closed |
|
|
SOS
27
Silver Oak Securities
Jackson,
Tennessee
| – | – | -20,188 | Closed |
|
|
XT
28
XTX Topco
George Town,
Cayman Islands
| – | – | -16,555 | Closed |
|
29
Millennium Management
New York
| – | – | -16,351 | Closed |
|